{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:15:20Z","timestamp":1793171720086,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T00:00:00Z","timestamp":1689984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prognostication is very important to clinicians and families during the early management of severe traumatic brain injury (sTBI), however, there are no gold standard biomarkers to determine prognosis in sTBI. As has been demonstrated in several diseases, early measurement of serum metabolomic profiles can be used as sensitive and specific biomarkers to predict outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We prospectively enrolled 59 adults with sTBI (Glasgow coma scale, GCS\u2009\u2264\u20098) in a multicenter Canadian TBI (CanTBI) study. Serum samples were drawn for metabolomic profiling on the 1st and 4th days following injury. The Glasgow outcome scale extended (GOSE) was collected at 3- and 12-months post-injury. Targeted direct infusion liquid chromatography-tandem mass spectrometry (DI\/LC\u2013MS\/MS) and untargeted proton nuclear magnetic resonance spectroscopy (\n                      <jats:sup>1<\/jats:sup>\n                      H-NMR) were used to profile serum metabolites. Multivariate analysis was used to determine the association between serum metabolomics and GOSE, dichotomized into favorable (GOSE 5\u20138) and unfavorable (GOSE 1\u20134), outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Serum metabolic profiles on days 1 and 4 post-injury were highly predictive (Q\n                      <jats:sup>2<\/jats:sup>\n                      \u2009&gt;\u20090.4\u20130.5) and highly accurate (AUC\u2009&gt;\u20090.99) to predict GOSE outcome at 3- and 12-months post-injury and mortality at 3\u00a0months. The metabolic profiles on day 4 were more predictive (Q\n                      <jats:sup>2<\/jats:sup>\n                      \u2009&gt;\u20090.55) than those measured on day 1 post-injury. Unfavorable outcomes were associated with considerable metabolite changes from day 1 to day 4 compared to favorable outcomes. Increased lysophosphatidylcholines, acylcarnitines, energy-related metabolites (glucose, lactate), aromatic amino acids, and glutamate were associated with poor outcomes and mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Metabolomic profiles were strongly associated with the prognosis of GOSE outcome at 3 and 12\u00a0months and mortality following sTBI in adults. The metabolic phenotypes on day 4 post-injury were more predictive and significant for predicting the sTBI outcome compared to the day 1 sample. This may reflect the larger contribution of secondary brain injury (day 4) to sTBI outcome. Patients with unfavorable outcomes demonstrated more metabolite changes from day 1 to day 4 post-injury. These findings highlighted increased concentration of neurobiomarkers such as N-acetylaspartate (NAA) and tyrosine, decreased concentrations of ketone bodies, and decreased urea cycle metabolites on day 4 presenting potential metabolites to predict the outcome. The current findings strongly support the use of serum metabolomics, that are shown to be better than clinical data, in determining prognosis in adults with sTBI in the early days post-injury. Our findings, however, require validation in a larger cohort of adults with sTBI to be used for clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-023-04573-9","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T09:01:44Z","timestamp":1690016504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Using metabolomics to predict severe traumatic brain injury outcome (GOSE) at 3 and 12\u00a0months"],"prefix":"10.1186","volume":"27","author":[{"given":"Mohammad M.","family":"Banoei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chel Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Panenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Wellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent W.","family":"Winston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Canadian biobank, database for Traumatic Brain Injury (CanTBI) investigators, the Canadian Critical Care Translational Biology Group (CCCTBG), the Canadian Traumatic Brain Injury Research, Clinical Network (CTRC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Joffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Yeates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Winston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Wellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Carrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Stukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Vercauteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Panenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audas","family":"Lorelei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Colantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Guerguerian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Gilfoyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Hutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili-Naz","family":"Hazrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Scratch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Khosroawshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,22]]},"reference":[{"issue":"4","key":"4573_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrneurol.2013.22","volume":"9","author":"B Roozenbeek","year":"2013","unstructured":"Roozenbeek B, Maas AI, Menon DK. Changing patterns in the epidemiology of traumatic brain injury. Nat Rev Neurol. 2013;9(4):231\u20136.","journal-title":"Nat Rev Neurol"},{"key":"4573_CR2","unstructured":"Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, Agrawal A, Adeleye AO, Shrime MG, Rubiano AM et al. Estimating the global incidence of traumatic brain injury. J Neurosurg 2018:1\u201318."},{"issue":"22","key":"4573_CR3","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJM199406023302206","volume":"330","author":"Multi-Society Task Force on PVS","year":"1994","unstructured":"Multi-Society Task Force on PVS. Medical aspects of the persistent vegetative state (2). N Engl J Med. 1994;330(22):1572\u20139.","journal-title":"N Engl J Med"},{"issue":"21","key":"4573_CR4","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJM199405263302107","volume":"330","author":"Multi-Society Task Force on PVS","year":"1994","unstructured":"Multi-Society Task Force on PVS. Medical aspects of the persistent vegetative state (1). N Engl J Med. 1994;330(21):1499\u2013508.","journal-title":"N Engl J Med"},{"issue":"5","key":"4573_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/neu.2000.17.403","volume":"17","author":"E Lannoo","year":"2000","unstructured":"Lannoo E, Van Rietvelde F, Colardyn F, Lemmerling M, Vandekerckhove T, Jannes C, De Soete G. Early predictors of mortality and morbidity after severe closed head injury. J Neurotrauma. 2000;17(5):403\u201314.","journal-title":"J Neurotrauma"},{"issue":"6","key":"4573_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3171\/jns.1982.57.6.0779","volume":"57","author":"A Levati","year":"1982","unstructured":"Levati A, Farina ML, Vecchi G, Rossanda M, Marrubini MB. Prognosis of severe head injuries. J Neurosurg. 1982;57(6):779\u201383.","journal-title":"J Neurosurg"},{"issue":"1","key":"4573_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1017\/S0317167100016930","volume":"32","author":"DA Zygun","year":"2005","unstructured":"Zygun DA, Laupland KB, Hader WJ, Kortbeek JB, Findlay C, Doig CJ, Hameed SM. Severe traumatic brain injury in a large Canadian health region. Can J Neurol Sci. 2005;32(1):87\u201392.","journal-title":"Can J Neurol Sci"},{"key":"4573_CR8","volume":"2012","author":"BD Greenwald","year":"2012","unstructured":"Greenwald BD, Ambrose AF, Armstrong GP. Mild brain injury. Rehabil Res Pract. 2012;2012: 469475.","journal-title":"Rehabil Res Pract"},{"issue":"12","key":"4573_CR9","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.apmr.2003.03.001","volume":"84","author":"PM Rees","year":"2003","unstructured":"Rees PM. Contemporary issues in mild traumatic brain injury. Arch Phys Med Rehabil. 2003;84(12):1885\u201394.","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"4573_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12028-012-9795-9","volume":"19","author":"B Jacobs","year":"2013","unstructured":"Jacobs B, Beems T, van der Vliet TM, van Vugt AB, Hoedemaekers C, Horn J, Franschman G, Haitsma I, van der Naalt J, Andriessen TM, et al. Outcome prediction in moderate and severe traumatic brain injury: a focus on computed tomography variables. Neurocrit Care. 2013;19(1):79\u201389.","journal-title":"Neurocrit Care"},{"issue":"18","key":"4573_CR11","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1089\/neu.2020.7448","volume":"38","author":"AJ Peters","year":"2021","unstructured":"Peters AJ, Schnell E, Saugstad JA, Treggiari MM. Longitudinal course of traumatic brain injury biomarkers for the prediction of clinical outcomes: a review. J Neurotrauma. 2021;38(18):2490\u2013501.","journal-title":"J Neurotrauma"},{"issue":"16","key":"4573_CR12","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1089\/neu.2017.5326","volume":"35","author":"MM Banoei","year":"2018","unstructured":"Banoei MM, Casault C, Metwaly SM, Winston BW. Metabolomics and biomarker discovery in traumatic brain injury. J Neurotrauma. 2018;35(16):1831\u201348.","journal-title":"J Neurotrauma"},{"issue":"4","key":"4573_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/1099800409346056","volume":"11","author":"AE Pasvogel","year":"2010","unstructured":"Pasvogel AE, Miketova P, Moore IM. Differences in CSF phospholipid concentration by traumatic brain injury outcome. Biol Res Nurs. 2010;11(4):325\u201331.","journal-title":"Biol Res Nurs"},{"issue":"4","key":"4573_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195318","volume":"13","author":"MS Fiandaca","year":"2018","unstructured":"Fiandaca MS, Mapstone M, Mahmoodi A, Gross T, Macciardi F, Cheema AK, Merchant-Borna K, Bazarian J, Federoff HJ. Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls. PLoS ONE. 2018;13(4): e0195318.","journal-title":"PLoS ONE"},{"issue":"1","key":"4573_CR15","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/s41467-022-30227-5","volume":"13","author":"I Thomas","year":"2022","unstructured":"Thomas I, Dickens AM, Posti JP, Czeiter E, Duberg D, Sinioja T, Kr\u00e5kstr\u00f6m M, Retel Helmrich IRA, Wang KKW, Maas AIR, et al. Serum metabolome associated with severity of acute traumatic brain injury. Nat Commun. 2022;13(1):2545.","journal-title":"Nat Commun"},{"issue":"9","key":"4573_CR16","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1097\/01.CCM.0000080484.72004.C4","volume":"31","author":"ME Kerr","year":"2003","unstructured":"Kerr ME, Ilyas Kamboh M, Yookyung K, Kraus MF, Puccio AM, DeKosky ST, Marion DW. Relationship between apoE4 allele and excitatory amino acid levels after traumatic brain injury. Crit Care Med. 2003;31(9):2371\u20139.","journal-title":"Crit Care Med"},{"issue":"2","key":"4573_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/01.CCM.0000153931.23488.DD","volume":"33","author":"AK Wagner","year":"2005","unstructured":"Wagner AK, Fabio A, Puccio AM, Hirschberg R, Li W, Zafonte RD, Marion DW. Gender associations with cerebrospinal fluid glutamate and lactate\/pyruvate levels after severe traumatic brain injury. Crit Care Med. 2005;33(2):407\u201313.","journal-title":"Crit Care Med"},{"issue":"3","key":"4573_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/jcmm.12998","volume":"21","author":"AM Amorini","year":"2017","unstructured":"Amorini AM, Lazzarino G, Di Pietro V, Signoretti S, Lazzarino G, Belli A, Tavazzi B. Severity of experimental traumatic brain injury modulates changes in concentrations of cerebral free amino acids. J Cell Mol Med. 2017;21(3):530\u201342.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"4573_CR19","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0003-9993(03)00148-5","volume":"84","author":"R Aquilani","year":"2003","unstructured":"Aquilani R, Iadarola P, Boschi F, Pistarini C, Arcidiaco P, Contardi A. Reduced plasma levels of tyrosine, precursor of brain catecholamines, and of essential amino acids in patients with severe traumatic brain injury after rehabilitation. Arch Phys Med Rehabil. 2003;84(9):1258\u201365.","journal-title":"Arch Phys Med Rehabil"},{"key":"4573_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12974-015-0328-2","volume":"12","author":"EB Yan","year":"2015","unstructured":"Yan EB, Frugier T, Lim CK, Heng B, Sundaram G, Tan M, Rosenfeld JV, Walker DW, Guillemin GJ, Morganti-Kossmann MC. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. J Neuroinflammation. 2015;12:110\u2013110.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"4573_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1089\/neu.2014.3495","volume":"32","author":"AS Alali","year":"2015","unstructured":"Alali AS, Vavrek D, Barber J, Dikmen S, Nathens AB, Temkin NR. Comparative study of outcome measures and analysis methods for traumatic brain injury trials. J Neurotrauma. 2015;32(8):581\u20139.","journal-title":"J Neurotrauma"},{"issue":"6","key":"4573_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/089771501750291819","volume":"18","author":"HS Levin","year":"2001","unstructured":"Levin HS, Boake C, Song J, McCauley S, Contant C, Diaz-Marchan P, Brundage S, Goodman H, Kotrla KJ. Validity and sensitivity to change of the extended Glasgow Outcome Scale in mild to moderate traumatic brain injury. J Neurotrauma. 2001;18(6):575\u201384.","journal-title":"J Neurotrauma"},{"issue":"1","key":"4573_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/1740774509356580","volume":"7","author":"GS McHugh","year":"2010","unstructured":"McHugh GS, Butcher I, Steyerberg EW, Marmarou A, Lu J, Lingsma HF, Weir J, Maas AI, Murray GD. A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project. Clin Trials (Lond England). 2010;7(1):44\u201357.","journal-title":"Clin Trials (Lond England)"},{"issue":"1","key":"4573_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nurt.2009.10.020","volume":"7","author":"AI Maas","year":"2010","unstructured":"Maas AI, Steyerberg EW, Marmarou A, McHugh GS, Lingsma HF, Butcher I, Lu J, Weir J, Roozenbeek B, Murray GD. IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics. 2010;7(1):127\u201334.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"4573_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2164-7-142","volume":"7","author":"RA van den Berg","year":"2006","unstructured":"van den Berg RA, Hoefsloot HCJ, Westerhuis JA, Smilde AK, van der Werf MJ. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics. 2006;7(1):142.","journal-title":"BMC Genomics"},{"issue":"1","key":"4573_CR26","first-page":"92","volume":"1","author":"B Worley","year":"2013","unstructured":"Worley B, Powers R. Multivariate analysis in metabolomics. Curr Metabol. 2013;1(1):92\u2013107.","journal-title":"Curr Metabol"},{"issue":"5","key":"4573_CR27","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1097\/CCM.0b013e31824519ce","volume":"40","author":"B Roozenbeek","year":"2012","unstructured":"Roozenbeek B, Lingsma HF, Lecky FE, Lu J, Weir J, Butcher I, McHugh GS, Murray GD, Perel P, Maas AI, et al. Prediction of outcome after moderate and severe traumatic brain injury: external validation of the International Mission on Prognosis and Analysis of Clinical Trials (IMPACT) and Corticoid Randomisation After Significant Head injury (CRASH) prognostic models. Crit Care Med. 2012;40(5):1609\u201317.","journal-title":"Crit Care Med"},{"key":"4573_CR28","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1089\/neu.2005.22.1025","volume":"22","author":"C Hukkelhoven","year":"2005","unstructured":"Hukkelhoven C, Steyerberg E, Habbema J, Farace E, Marmarou A, Murray G, Marshall L, Maas A. Predicting outcome after traumatic brain injury: development and validation of a prognostic score based on admission characteristics. J Neurotrauma. 2005;22:1025\u201339.","journal-title":"J Neurotrauma"},{"issue":"7","key":"4573_CR29","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1089\/neu.2011.1988","volume":"29","author":"B Roozenbeek","year":"2012","unstructured":"Roozenbeek B, Chiu Y-L, Lingsma HF, Gerber LM, Steyerberg EW, Ghajar J, Maas AIR. Predicting 14-day mortality after severe traumatic brain injury: application of the IMPACT models in the brain trauma foundation TBI-trac\u00ae New York State database. J Neurotrauma. 2012;29(7):1306\u201312.","journal-title":"J Neurotrauma"},{"issue":"8","key":"4573_CR30","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1089\/neu.2008.0841","volume":"26","author":"D Low","year":"2009","unstructured":"Low D, Kuralmani V, Ng SK, Lee KK, Ng I, Ang BT. Prediction of outcome utilizing both physiological and biochemical parameters in severe head injury. J Neurotrauma. 2009;26(8):1177\u201382.","journal-title":"J Neurotrauma"},{"issue":"7","key":"4573_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158762","volume":"11","author":"Z Zador","year":"2016","unstructured":"Zador Z, Sperrin M, King AT. Predictors of outcome in traumatic brain injury: new insight using receiver operating curve indices and Bayesian network analysis. PLoS ONE. 2016;11(7): e0158762.","journal-title":"PLoS ONE"},{"issue":"3","key":"4573_CR32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00216-004-2783-y","volume":"380","author":"L Eriksson","year":"2004","unstructured":"Eriksson L, Antti H, Gottfries J, Holmes E, Johansson E, Lindgren F, Long I, Lundstedt T, Trygg J, Wold S. Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal Bioanal Chem. 2004;380(3):419\u201329.","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"4573_CR33","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/ijms20051149","volume":"20","author":"S-H Law","year":"2019","unstructured":"Law S-H, Chan M-L, Marathe GK, Parveen F, Chen C-H, Ke L-Y. An updated review of lysophosphatidylcholine metabolism in human diseases. Int J Mol Sci. 2019;20(5):1149.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4573_CR34","doi-asserted-by":"publisher","first-page":"11263","DOI":"10.1038\/s41598-017-11766-0","volume":"7","author":"D Sugasini","year":"2017","unstructured":"Sugasini D, Thomas R, Yalagala PCR, Tai LM, Subbaiah PV. Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice. Sci Rep. 2017;7(1):11263.","journal-title":"Sci Rep"},{"issue":"2","key":"4573_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/MAJ.0000000000000506","volume":"350","author":"JB Hiebert","year":"2015","unstructured":"Hiebert JB, Shen Q, Thimmesch AR, Pierce JD. Traumatic brain injury and mitochondrial dysfunction. Am J Med Sci. 2015;350(2):132\u20138.","journal-title":"Am J Med Sci"},{"issue":"4","key":"4573_CR36","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1476-5381.2012.02025.x","volume":"167","author":"G Cheng","year":"2012","unstructured":"Cheng G, Kong RH, Zhang LM, Zhang JN. Mitochondria in traumatic brain injury and mitochondrial-targeted multipotential therapeutic strategies. Br J Pharmacol. 2012;167(4):699\u2013719.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"4573_CR37","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00004647-199806000-00002","volume":"18","author":"EH Sinz","year":"1998","unstructured":"Sinz EH, Kochanek PM, Heyes MP, Wisniewski SR, Bell MJ, Clark RSB, DeKosky ST, Blight AR, Marion DW. Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans. J Cereb Blood Flow Metab. 1998;18(6):610\u20135.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"4573_CR38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s11481-014-9578-5","volume":"10","author":"ME Dumas","year":"2015","unstructured":"Dumas ME, Davidovic L. Metabolic profiling and phenotyping of central nervous system diseases: metabolites bring insights into brain dysfunctions. J Neuroimmune Pharmacol. 2015;10(3):402\u201324.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"43","key":"4573_CR39","doi-asserted-by":"publisher","first-page":"71052","DOI":"10.18632\/oncotarget.11958","volume":"7","author":"J Shi","year":"2016","unstructured":"Shi J, Dong B, Mao Y, Guan W, Cao J, Zhu R, Wang S. Review: Traumatic brain injury and hyperglycemia, a potentially modifiable risk factor. Oncotarget. 2016;7(43):71052\u201361.","journal-title":"Oncotarget"},{"key":"4573_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fnins.2015.00112","volume":"9","author":"KL Carpenter","year":"2015","unstructured":"Carpenter KL, Jalloh I, Hutchinson PJ. Glycolysis and the significance of lactate in traumatic brain injury. Front Neurosci. 2015;9:112.","journal-title":"Front Neurosci"},{"key":"4573_CR41","first-page":"408","volume":"8","author":"GA Brooks","year":"2014","unstructured":"Brooks GA, Martin NA. Cerebral metabolism following traumatic brain injury: new discoveries with implications for treatment. Front Neurosci. 2014;8:408.","journal-title":"Front Neurosci"},{"key":"4573_CR42","doi-asserted-by":"crossref","unstructured":"Mondello S, Sandner V, Goli M, Czeiter E, Amrein K, Kochanek PM, Gautam S, Cho BG, Morgan R, Nehme A et al. Exploring serum glycome patterns after moderate to severe traumatic brain injury: a prospective pilot study. eClinicalMedicine. 2022;50.","DOI":"10.1016\/j.eclinm.2022.101494"},{"key":"4573_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-4020-8831-5_9","volume":"49","author":"RM Adibhatla","year":"2008","unstructured":"Adibhatla RM, Hatcher JF. Altered lipid metabolism in brain injury and disorders. Subcell Biochem. 2008;49:241\u201368.","journal-title":"Subcell Biochem"},{"key":"4573_CR44","doi-asserted-by":"crossref","unstructured":"Ng SY, Lee AYW. Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci. 2019;13.","DOI":"10.3389\/fncel.2019.00528"},{"issue":"3","key":"4573_CR45","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00726-011-1202-x","volume":"43","author":"RN Vuille-Dit-Bille","year":"2012","unstructured":"Vuille-Dit-Bille RN, Ha-Huy R, Stover JF. Changes in plasma phenylalanine, isoleucine, leucine, and valine are associated with significant changes in intracranial pressure and jugular venous oxygen saturation in patients with severe traumatic brain injury. Amino Acids. 2012;43(3):1287\u201396.","journal-title":"Amino Acids"},{"issue":"7549","key":"4573_CR46","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","volume":"332","author":"DG Altman","year":"2006","unstructured":"Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ (Clin Res Ed). 2006;332(7549):1080.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"24","key":"4573_CR47","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1089\/neu.2019.6969","volume":"37","author":"SD Yeatts","year":"2020","unstructured":"Yeatts SD, Martin RH, Meurer W, Silbergleit R, Rockswold GL, Barsan WG, Korley FK, Wright DW, Gajewski BJ. Sliding scoring of the glasgow outcome scale-extended as primary outcome in traumatic brain injury trials. J Neurotrauma. 2020;37(24):2674\u20139.","journal-title":"J Neurotrauma"},{"key":"4573_CR48","volume-title":"Acute Pathophysiology of Blast Injury From Biomechanics to Experiments and Computations Implications on Head and Polytrauma Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects","author":"NSA Chandra","year":"2015","unstructured":"Chandra NSA. Acute Pathophysiology of Blast Injury From Biomechanics to Experiments and Computations Implications on Head and Polytrauma Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton: Taylor & Francis Group, LLC; 2015."},{"issue":"6","key":"4573_CR49","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1089\/neu.2010.1561","volume":"28","author":"A Gyorgy","year":"2011","unstructured":"Gyorgy A, Ling G, Wingo D, Walker J, Tong L, Parks S, Januszkiewicz A, Baumann R, Agoston DV. Time-dependent changes in serum biomarker levels after blast traumatic brain injury. J Neurotrauma. 2011;28(6):1121\u20136.","journal-title":"J Neurotrauma"},{"issue":"11","key":"4573_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029072","volume":"9","author":"X Chen","year":"2019","unstructured":"Chen X, Sara H, Vincy C, Zheng Jing H, Mitchell S, Michael E, Angela C, Tatyana M. Comorbidity in adults with traumatic brain injury and all-cause mortality: a systematic review. BMJ Open. 2019;9(11): e029072.","journal-title":"BMJ Open"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04573-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04573-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04573-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T10:02:22Z","timestamp":1690020142000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04573-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,22]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4573"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04573-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2613141\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,22]]},"assertion":[{"value":"21 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Conjoint Health Research Ethics Board at the University of Calgary, Canada. Written informed consent was obtained from all patients or their surrogates.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"295"}}